Search results for the GEO ID: GSE48441
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM1178760
GPL201
HepG2 control rep1 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: control
GSM1178761
GPL201
HepG2 control rep2 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: control
GSM1178762
GPL201
HepG2 control rep3 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: control
GSM1178763
GPL201
HepG2 0.005 microM rep1 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 0.005 µM arsenic trioxide
GSM1178764
GPL201
HepG2 0.005 microM rep2 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 0.005 µM arsenic trioxide
GSM1178765
GPL201
HepG2 0.005 microM rep3 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 0.005 µM arsenic trioxide
GSM1178766
GPL201
HepG2 0.07 microM rep1 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 0.07 µM arsenic trioxide
GSM1178767
GPL201
HepG2 0.07 microM rep2 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 0.07 µM arsenic trioxide
GSM1178768
GPL201
HepG2 0.07 microM rep3 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 0.07 µM arsenic trioxide
GSM1178769
GPL201
HepG2 0.5 microM rep1 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 0.5 µM arsenic trioxide
GSM1178770
GPL201
HepG2 0.5 microM rep2 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 0.5 µM arsenic trioxide
GSM1178771
GPL201
HepG2 0.5 microM rep3 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 0.5 µM arsenic trioxide
GSM1178772
GPL201
HepG2 6 microM rep1 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 6 µM arsenic trioxide
GSM1178773
GPL201
HepG2 6 microM rep2 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 6 µM arsenic trioxide
GSM1178774
GPL201
HepG2 6 microM rep3 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 6 µM arsenic trioxide
GSM1178775
GPL201
HepG2 40 microM rep1 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 40 µM arsenic trioxide
GSM1178776
GPL201
HepG2 40 microM rep2 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 40 µM arsenic trioxide
GSM1178777
GPL201
HepG2 40 microM rep3 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 40 µM arsenic trioxide
GSM1178778
GPL201
HepG2 CAP rep1 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 15 mM ε-caprolactam
GSM1178779
GPL201
HepG2 CAP rep2 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 15 mM ε-caprolactam
GSM1178780
GPL201
HepG2 CAP rep3 human hepatoma cell line, HepG2 cell bank no: RCB1648 Sex: male age of sampling: 15 years tissue derived: liver case history: hepatocyte carcinoma life span: infinite classification: transformed treatment: exposed to 15 mM ε-caprolactam
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes